INS and metabolic dysfunction-associated steatotic liver disease: Conversely, anti‐inflammatory flavonoids (e.g., flavanones) (Bell et al. 2024) and dietary fiber (Akhgarjand et al. 2024; Chen et al. 2024), prioritized in the FII, reduce serum cholesterol and improve insulin sensitivity, mitigating MASLD progression.